Prodrugs and Targeted Delivery: Towards Better ADME Properties, Volume 47 [NOOK Book]

Overview

This topical reference and handbook addresses the chemistry, pharmacology, toxicology and the patentability of prodrugs, perfectly mirroring the integrated approach prevalent in today's drug design. It summarizes current experiences and strategies for the rational design of prodrugs, beginning at the early stages of the development process, as well as discussing organ- and site-selective prodrugs.
Every company employing medicinal chemists will be interested in this ...
See more details below
Prodrugs and Targeted Delivery: Towards Better ADME Properties, Volume 47

Available on NOOK devices and apps  
  • NOOK Devices
  • Samsung Galaxy Tab 4 NOOK 7.0
  • Samsung Galaxy Tab 4 NOOK 10.1
  • NOOK HD Tablet
  • NOOK HD+ Tablet
  • NOOK eReaders
  • NOOK Color
  • NOOK Tablet
  • Tablet/Phone
  • NOOK for Windows 8 Tablet
  • NOOK for iOS
  • NOOK for Android
  • NOOK Kids for iPad
  • PC/Mac
  • NOOK for Windows 8
  • NOOK for PC
  • NOOK for Mac
  • NOOK for Web

Want a NOOK? Explore Now

NOOK Book (eBook)
$117.99
BN.com price
(Save 43%)$207.00 List Price
Note: This NOOK Book can be purchased in bulk. Please email us for more information.

Overview

This topical reference and handbook addresses the chemistry, pharmacology, toxicology and the patentability of prodrugs, perfectly mirroring the integrated approach prevalent in today's drug design. It summarizes current experiences and strategies for the rational design of prodrugs, beginning at the early stages of the development process, as well as discussing organ- and site-selective prodrugs.
Every company employing medicinal chemists will be interested in this practice-oriented overview of a key strategy in modern drug discovery and development.
Read More Show Less

Editorial Reviews

From the Publisher
"The book captures all the important aspects of prodrugs. It is well organized in that each chapter presents a specific topic with very little duplication of contents between chapters . . . Given the fact that prodrugs are now increasingly integrated into early drug discovery, this type of book would be a valuable addition to the library of any drug discovery institution." (Journal of Medicinal Chemistry, 8 August 2011)

"Every company employing medicinal chemists will be interested in this practice-oriented overview of a key strategy in modern drug discovery and development." (Pharmiweb, 16 February 2011)

Read More Show Less

Product Details

Meet the Author

Jarkko Rautio is professor of pharmaceutical chemistry and head of the multidisciplinary Pharmaceutical and Medicinal Chemistry (PMC) research group at the School of Pharmacy, University of Eastern Finland (formerly University of Kuopio), where he received his PhD in pharmaceutical chemistry in 2000. He subsequently carried out his postdoctoral studies at the University of Maryland, Baltimore, USA, and was a visiting scientist at GlaxoSmithKline, North Carolina, while also co-founding the American Association of Pharmaceutical Scientists (AAPS) Prodrug Focus Group in 2005. Professor Rautio's research focuses on chemistry-based methods, especially prodrugs, to overcome the liabilities of drugs.
Read More Show Less

Table of Contents

Preface

PART ONE: Prodrug Design and Intellectual Property

PRODRUG STRATEGIES IN DRUG DESIGN
Prodrug Concept
Basics of Prodrug Design
Rationale for Prodrug Design
History of Prodrug Design
Recently Marketed Prodrugs
Concluding Remarks

THE MOLECULAR DESIGN OF PRODRUGS BY FUNCTIONAL GROUP
Introduction
The Prodrug Concept and Basics of Design
Common Functional Group Approaches in Prodrug Design
Conclusions

INTELLECTUAL PROPERTY PRIMER ON PHRAMACEUTICAL PATENTS WITH A SPECIAL EMPHASIS ON PRODRUGS AND METABOLITES
Introduction
Patents and FDA Approval Process
Obtaining a Patent
Conclusion

PART TWO: Prodrugs Addressing ADMET Issues

INCREADING LIPOPHILICITY FOR ORAL DRUG DELIVERY
Introduction
pKa, Degree of Ionization, Partition Coefficient, and Distribution Coefficient
Prodrug Strategies to Enhance Lipid Solubility
Prodrug Examples for Antibiotics
Antiviral Related Prodrugs
Cardiovascular Related Prodrugs
Lipophilic Prodrugs of Benzamidine Drugs
Miscellaneous Examples
Summary and Conclusion

MODULATING SOLUBILITY THROUGH PRODRUGS FOR ORAL AND IV DRUG DELIVERY
Introduction
Basics of Solubility and Oral/IV Drug Delivery
Prodrug Applications for Enhanced Aqueous Solubility
Challenges with Solubilizing Prodrugs of Insoluble Drugs
Additional Applications of Prodrugs for Modulating Solubility
Parallel Exploration of Analogues and Prodrugs in Drug Discovery (Commentary)
Conclusions

PRODRUGS DESIGNED TO TARGET TRANSPORTERS FOR ORAL DRUG DELIVERY
Introduction
Serendipity: An Actively Transported Prodrug
Requirements for Actively Transported Prodrugs
Peptide Transporters: PEPT1 and PEPT2
Monocarboxylate Transporters
Bile Acid Transporters
Conclusions

TOPICAL AND TRANSDERMAL DELIVERY USING PRODRUGS: MECHANISM OF ENHANCEMENT
Introduction
Arrangement of Water in the Stratum Corneum
A New Model for Diffusion Through the Stratum Corneum: The Biphasic Solubility Model
Equations for Quantifying Effects of Solubility on Diffusion Through the Stratum Corneum
Design of Prodrugs for Topical and Transdermal Delivery Based on the Biphasic Solubility Model
Comparison of Human and Mouse Skin Experiments
Summary

OCULAR DELIVERY USING PRODRUGS
Introduction
Criteria for an Ideal Ophthalmic Prodrug
Anatomy and Physiology of the Eye
Barriers to Ocular Drug Delivery
Influx and Efflux Transporters on the Eye
Transporter-Targeted Prodrug Approach
Drug Disposition in Ocular Delivery
Effect of Physiochemical Factors on Drug Disposition in Eye
Prodrug Strategy to Improve Ocular Bioavailability (Nontransporter-Targeted Approach)
Recent Patents and Marketed Ocular Prodrugs
Novel Formulation Approaches for Sustained Delivery of Prodrugs
Conclusion

REDUCING PRESYSTEMIC DRUG METABOLISM
Introduction
Presystemic Metabolic Barriers
Prodrug Approaches to Reduce Presystemic Drug Metabolism
Targeting Colon
Targeting Lymphatic Route
Conclusion

ENZYME-ACTIVATED PRODRUG STRATEGIES FOR SITE-SELECTIVE DRUG DELIVERY
Introduction
General Requirements for Enzyme-Activated Targeted Prodrug Strategy
Examples of Targeted Prodrug Strategies
Summary

PRODRUG APPROACHES FOR CENTRAL NERVOUS SYSTEM DELIVERY
Blood-Brain Barrier in CNS Drug Development
Prodrug Strategies
Prodrug Strategies Based Upon BBB Nutrient Transporters
Prodrug Strategies Based Upon BBB Receptors
CNS Prodrug Summary

DIRECTED ENZYME PRODRUG THERAPIES
Introduction
Theoretical Background of DEPT
Comparison of ADEPT and GDEPT
Enzymes in ADEPT and GDEPT
Design of Prodrugs
Strategies Used for the Improvement of DEPT Systems
Biological Data for ADEPT and GDEPT
Conclusions

PART THREE: Codrugs and Soft Drugs

IMPROVING THE USE OF DRUG COMBINATIONS THROUGH THE CODRUG APPROACH
Codrugs and Codrug Strategy
Ideal Codrug Characteristics
Examples of Marketed Codrugs
Topical Codrug Therapy for the Treatment of Ophthalmic Diseases
Codrugs for Transdermal Delivery
Codrugs of L-DOPA for the Treatment of Parkinson's Disease
Analgesic Codrugs Containing Nonsteroidal Anti-Inflammatory Agents
Analgesic Codrugs of Opioids and Cannabinoi
Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)